A.
Addiction potential.
✓
C.
Respiratory depression.
✓
A.
Inhibiting fungal cell wall synthesis.
✓
B.
Inhibiting fungal DNA synthesis.
✓
C.
Inhibiting ergosterol synthesis, a critical component of the fungal cell membrane.
✓
D.
Disrupting fungal ribosomes.
✓
A.
Decreased metabolism of warfarin, leading to increased INR.
✓
B.
Increased metabolism of oral contraceptives, leading to reduced efficacy.
✓
C.
Decreased absorption of iron supplements.
✓
D.
Increased renal excretion of digoxin.
✓
B.
Tendonitis and tendon rupture.
✓
B.
Inhaled long-acting ?2?-agonist.
✓
C.
Systemic corticosteroids (e.g., intravenous methylprednisolone).
✓
A.
Primarily lowering LDL cholesterol.
✓
B.
Primarily lowering triglycerides and modestly raising HDL cholesterol.
✓
C.
Primarily raising total cholesterol.
✓
D.
Primarily raising LDL cholesterol.
✓
A.
To minimize adverse effects.
✓
B.
To simplify the dosing regimen.
✓
C.
To overcome and prevent antibiotic resistance.
✓
D.
To increase patient compliance.
✓
A.
Increasing insulin secretion.
✓
B.
Decreasing hepatic glucose production.
✓
C.
Inhibiting sodium-glucose co-transporter 2 (SGLT2) in the kidneys, leading to increased glucose excretion.
✓
D.
Enhancing insulin sensitivity.
✓
Page 945 of 1122
Jump to:
